Next week on the stock market
We take a look at what to expect from a selection of FTSE 100, FTSE 250 and selected other companies reporting next week.

Important notes
This article isn’t personal advice. If you’re not sure whether an investment is right for you please seek advice. If you choose to invest the value of your investment will rise and fall, so you could get back less than you put in.
14 January 2021
Netflix kicks things off for the tech sector next week, as well as offering investors some insight on how well the stay-at-home stocks held up through the back-half of the year.
Retail will also take the stage once again. Burberry’s results are a litmus test for luxury goods. With a potential economic downturn on the cards, we’ll see whether consumers splashed out during the festive period. By comparison Pets at Home could be a dark horse in the sector if it’s able to take advantage of the lockdown puppy boom.
- We’ll be looking for evidence that Pets at Home can translate its lockdown boom into online growth and higher margin sales
- EMIS could see revenue and profits remain stable
- Ibstock will tell us how much the second wave has disrupted demand
FTSE 100, FTSE 250 and selected other stocks scheduled to report next week
18-Jan | |
---|---|
No FTSE 350 Reporters |
19-Jan | |
---|---|
BHP Group | Q2 Production Report |
Centamin | Q4 Trading Statement |
Experian* | Q3 Trading Statement |
Integrafin | Q1 Trading Statement |
Netflix* | Q4 Trading Statement |
Premier Foods | Q3 Trading Statement |
Rio Tinto | Q4 Production Report |
20-Jan | |
---|---|
Antofagasta | Q4 Trading Statement |
Burberry Group* | Q3 Trading Statement |
Cairn | Trading Statement |
CMC Markets | Q3 Trading Statement |
Diploma | Q1 Trading Statement |
Dixons Carphone* | Q3 Trading Statement |
WH Smith | Christmas Trading Statement |
21-Jan | |
---|---|
AJ Bell | Q1 Trading Statement |
Close Brothers | Trading Statement |
Countryside Properties | Q1 Trading Statement |
EMIS Group* | Trading Statement |
Ibstock* | Full Year Trading Statement |
IG Group | Interim Results |
Pets at Home* | Q3 Trading Statement |
Sage | Q1 Trading Statement |
22-Jan | |
---|---|
Computacenter | Trading Statement |
Ninety One | Q3 Trading Statement |
*Companies on which we will be writing research.
Ibstock – Nicholas Hyett, Equity Analyst
In October Ibstock was expecting full year cash profits (EBITDA) of around £50m, compared to £122m last year. Since the year-end was 31 December, the most recent national lockdown shouldn’t have affected results.
The group has primarily been hurt by lower demand for construction materials due to disruption to building activity, especially during the first lockdown. However, by September volumes had recovered to 90% of 2019 levels. The November lockdown and Christmas disruption may have hurt results but, as building sites kept running, we doubt the effect will be significant. Margins were also improving in October thanks to the group’s cost control measures and improving volumes.
Net debt has increased over the year, but in October Ibstock was expecting a reduction from the £103m reported at the half year. Management plans to reduce debt quickly in 2021, although this will rely on construction demand remaining stable.
In the medium term we expect government support for housebuilding and investment in infrastructure to help the group, but if lockdown measures tighten it could cause disruption in the months ahead.
See the Ibstock share price, charts and how to deal
Sign up to receive Ibstock research direct to your inbox
EMIS – Nicholas Hyett, Equity Analyst
As the UK’s leading provider of practice management software to GP’s surgeries, EMIS has been able to navigate the pandemic without too many problems.
Sales fell just 2% in the first half of 2020, largely down to coronavirus related disruption to new implementations, with recurring revenues improving. The group has seen sales of some of its remote working products, such as EMIS Mobile and Anywhere Consult, rise as doctors seek to reduce face-to-face contact. Meanwhile direct to patient services have added millions of new users as digital delivery of healthcare services increased.
We’d expect those recent trends to have continued over the last quarter. Given the very strong cash conversion in the first half that’s likely to leave the company with plenty of cash in the bank. Analysts are forecasting a 3% yield over the next 12 months, but we think that will still leave the company with extra cash. How that gets used is something to watch – acquisitions, increased investment or bonus shareholders returns are all possibilities.
See the EMIS share price, charts and how to deal
Sign up to receive EMIS research direct to your inbox
Pets at Home, Sophie Lund Yates, Equity Analyst
We already know things are going well at Pets at Home. The group upgraded full year profit expectations at the start of January. Underlying pre-tax profit is now expected to be ahead of previous guidance, at £77m. (This includes the repayment of business rate relief).
Pet ownership increased massively in the pandemic, helping group sales rise over 5% at the half year. But that doesn’t mean there aren’t things to watch out for. Lower margin items like cat litter have been flying off the shelves. Eventually Pets will want customers to snap up more profitable items. We’d like to know if there was any evidence of a spending shift in Q3. Stricter lockdowns are also likely to impact performance, any update on more recent trading would be good.
Momentum has accelerated both in store and online, with high-teens like-for-like growth overall in December. It will be worth paying particular attention to how fast the online business is growing. There is huge competition online, and Pets has invested heavily in new infrastructure. In order to be profitable this division needs to continue growing at an impressive rate. At the half year, online sales were up 65.8%.
See the Pets at Home share price, charts and how to deal
Sign up to receive Pets at Home research direct to your inbox
Unless otherwise stated estimates are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Past performance is not a guide to the future. Investments and income they produce can rise and fall in value so investors could make a loss.
This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.
Help us make our articles easier to read
Take a few minutes to help us improve the fonts we use by giving us your feedback on a sample article.
Please correct the following errors before you continue:
Hargreaves Lansdown PLC group companies will usually send you further information by post and/or email about our products and services. If you would prefer not to receive this, please do let us know. We will not sell or trade your personal data.
What did you think of this article?
Important notes
This article isn’t personal advice. If you’re not sure whether an investment is right for you please seek advice. If you choose to invest the value of your investment will rise and fall, so you could get back less than you put in.
Editor's choice – our weekly email
Sign up to receive the week's top investment stories from Hargreaves Lansdown. Including:
- Latest comment on economies and markets
- Expert investment research
- Financial planning tips